Pan-cancer analysis reveals dual roles of HES6 in cancer immunity and prognosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.HES6 is overexpressed in many cancers and predicts survival outcomes. This gene may serve as a novel clinical biomarker for solid tumors, especially gliomas.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- HES6 (Hes family bHLH transcription factor 6) is implicated in tumor progression and patient survival.
- Its role in oncogenesis and association with the tumor immune microenvironment requires further investigation.
Purpose Of The Study
- To conduct a pan-cancer analysis of HES6 expression, clinical implications, and prognostic significance.
- To elucidate the biological mechanisms of HES6 in oncogenesis and its association with immune cells and signaling pathways.
Main Methods
- Pan-cancer analysis of HES6 expression and clinical data.
- Investigation of gene expression profiles, immune cell enrichment, and signaling pathway involvement.
- Exploration of HES6 interactions with other proteins and genes.
Main Results
- HES6 is overexpressed across various cancer types compared to normal tissues.
- HES6 expression correlates with patient survival and the immune microenvironment, particularly CD8+ T cells and macrophages.
- HES6 is enriched in key oncogenic pathways like Epithelial-Mesenchymal Transition, NOTCH, and Wnt signaling.
Conclusions
- HES6 plays a significant role in solid tumor progression and patient prognosis.
- HES6 is associated with immune and inflammation-related genes, suggesting immunomodulatory functions.
- HES6 is a potential predictive biomarker for solid tumors, with gliomas as a primary focus.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...